Assessment and prediction of functional impairment in vascular dementia

Expert Review of Neurotherapeutics

Volumn 4, Issue 1, 2004, Pages 109-114

  Boyle, Patricia A ^a   Cahn Weiner, Deborah ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Activities of daily living; Assessment; Dementia; Prediction

Indexed keywords

AGING; CLINICAL PRACTICE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DISABILITY; EXECUTIVE DYSFUNCTION; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HIGH RISK PATIENT; HUMAN; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; PHYSICAL DISEASE; QUALITY OF LIFE; REVIEW;

ACTIVITIES OF DAILY LIVING; COGNITION DISORDERS; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0347753738     PISSN: 14737175     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737175.4.1.109     Document Type: Review

References (36)

1. Aguero-Torres HL, Fratiglioni L, Winblad B. Natural history of Alzheimer's disease and other dementias: review of the literature in the light of the findings from the Kungsholmen Project. Int. J. Geriat. Psy. 13(11), 755-766 (1998).
2. Cummings JL. Vascular subcortical dementias: clinical aspects. Dementia 5(3-4), 177-180 (1994).
3. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9(3), 179-186 (1969).
4. Severson MA, Smith GF, Tangalos EG et al. Patterns and predictors of institutionalization in community-based dementia patients. J. Am. Geriat. Soc. 42(2), 181-185 (1994).
5. Hope T, Keene J, Gedling K, Fairburn CG, Jacoby R. Predictors of institutionalization for people with dementia living at home with a carer. Int. J. Geriat. Psych. 13(10), 682-690 (1998).
6. Vetter PH, Krauss S, Steiner O et al. Vascular dementia versus dementia of Alzheimer's type: do they have differential effects on caregivers' burden? J. Gerontolological Behav. Psychological Science Soc. 54(2), S93-S98 (1999).
7. American Psychiatric Association Diagnostic criteria from the DSM-IV-TR. American Psychiatric Association. DC, USA, 90-91 (2000).
8. Roman GC, Tatemichi TK, Erkinjutti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43, 250-260 (1993).
9. Gauthier S, Rockwood K, Gelinas I et al. Outcome measures for the study of activities of daily living in vascular dementia. Alzheimer's Dis. Associated Dis. 13(S3), 143-147 (1999).
10. Lawton MP, Brody EM. Assessment of older people; self maintaining and instrumental activities of daily living. Gerontologist 179-186 (1969).
11. DeJong R, Osterland O, Roy G. Measurement of quality of life changes in patients with Alzheimer's disease. Clin. Ther. 11, 545-554 (1989).
12. Gelinas I, Gauthier I, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer's disease. Am. J. Occupational Ther. 53, 471-481 (1999).
13. Galasko D, Bennet D, Sano M et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. Alzheimer's Dis. Associated. Dis. 11, S33-S39 (1997).
14. Erkinjuntti T, Kurz A, Gauthier S et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's combined with cerebrovascular disease a randomized clinical trial. Lancet 359(9314), 1283-1290 (2002).
15. Raskind M, Mintzer J, Mehnert A, Ferris SH. Decline in ability to perform ADLs in patients with Alzheimer's disease not receiving treatment. J. Neurological. Sci. 187, S140-S141 (2001).
16. Feldman H, Sauter A, Donald et al. The Disability Assessment for Dementia Scale: a 12-month study of functional ability in mild-moderate severity Alzheimer's disease. Alzheimer's Dis. Associated Dis. 15, 89-95 (2001).
17. Kitter B. For the European/Canadian Propentofylline Study Group. Clinical trials of propentofylline in vascular dementia. Alzheimer's Dis. Assoc. Dis. 13(Suppl. 3) S166-S171 (1999).
18. Nyenhuis DL, Gorelick PB, Freels S, Garron D. Cognitive and functional decline in African Americans with VaD, AD and stroke without dementia. Neurology 58(1), 56-61 (2002).
19. Boyle P, Paul F, Moser D, Cohen R. Executive dysfunction predicts ADL declines in patients with vascular dementia. Clin. Neuropsychol. (In Press).
20. Mitnitski AB, Graham JE, Mogilner AJ, Rockwood K. The rate of dedine in function in Alzheimer's disease and other dementias. J. Gerontological Biological Sci. Med. Soc. 54(2), M65-M69 (1999).
21. Paul RH, Cohen RA, Moser D, Browndike J, Zawacki T, Gordon N. Performance on the Mattis Dementia Rating Scale in patients with vascular dementia: relationships to neuroimaging findings. J. Geriat. Psych. Neurol. 14(1), 33-36 (2001).
22. Tomaszewski S, Farias S, Mackin S, Mungas D, Reed B, Jagust W. Differences in degree of impaired daily functionoing in different dementia types. Arch. Clin. Neuropsychol. 17, 735 (2002).
23. Almkvist O. Neuropsychological deficits in vascular dementia in relation to Alzheimer's disease: reviewing evidence for functional similarity or divergence. Dementia 5(3-4), 203-209 (1994).
24. Libon DL, Bogdanoff B, Swenson R et al. Neuropsychological profiles associated with subcortical white matter alterations and Parkinson's disease: implications for the diagnosis of dementia. Arch. Clin. Neuropsychol. 16, 19-32 (2001).
25. Roman GC, Royall DR. Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer's Dis. Associated Dis. 13(S3), 69-80 (1999).
26. Royall DR, Roman DC. Differentiation of vascular dementia from Alzheimer's disease on neuropsychological tests. Neurology 55(4), 604-606 (2000).
27. Bell-McGinty S, Podell K, Franzen M, Baird A, Williams M. Standard measures of executive function in predicting IADLs in older adults. Int. J. Geriat Psych. (2003) (In Press).
28. Grigsby J, Kaye K, Baxter J, Shetterly S, Hamman R. Executive cognitive abilities and functional status among community-dwelling older persons in the San Luis Valley Health and Aging Study. J. Am. Geriatrics Soc. 46(5), 590-596 (1998).
29. Boyle P, Malloy P, Salloway S, Cahn-Weiner D, Cohen R, Cummings JL. Executive dysfunction and apathy predict functional impairment in Alzheimer's disease. Am. J. Geriat. Psych. 11(2), 214-221 (2003).
30. Chen ST, Sultzer DL, Hinkin C, Mahler M, Cummings JE. Executive dysfunction in Alzheimer's disease: association with neuropsychiatric symptoms and functional impairment. J. Neuropsych. Clin. Neurosci. 10(4), 426-432 (1998).
31. Norton LE, Malloy PF, Salloway S. The impact of behavioral symptoms on activities of daily living in patients with dementia. Am. J. Geriat. Psy. 9(1), 41-48 (2001).
32. Lezak MD. Neuropsychological Assessment. Oxford University Press, NY, USA (1995).
33. Boyle P, Cohen R, Paul R, Moser D, Gordon N. Cognitive and motor impairments predict functional declines in vascular dementia. Int. J. Geriat. Psych. 17(2), 164-169 (2002).
34. Mattis S. Dementia Rating Scale Professional Manual. Psychological Assessment Resources, Fl, USA (1973).
35. Boyle P, Paul R, Moser D, Zawacki T, Gordon N, Cohen R. Cognitive and neurologic predictors of functional impairment in vascular dementia. Am. J. Geriat. Psych. 11(1), 103-106 (2003).
36. Bennett HP, Corbett AJ, Gaden S, Grayson DA, Kril JJ, Broe GA. Subcortical vascular disease and functional decline: a 6-year predictor study. J. Am. Geriat. Soc. 50(12), 1969-1977 (2002).